News summaryStablecoin Development / NYSE American statement, reported by TipRanksOct 13, 2026, 12:00 PM

Mizuho raised Dexcom price target to $100 from $95; Buy maintained

DXCMequity_marketspersonal_finance

On October 13, 2026, Mizuho analyst Anthony Petrone raised his DXCM target to $100 from $95 and maintained Buy. The stock closed at $85.06 that day, down 1.0% from October 12’s $85.92 close.